We are live on ! Find out more
BIAF icon

bioAffinity Technologies
BIAF

5 hedge funds and large institutions have $193K invested in bioAffinity Technologies in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

67% more funds holding

Funds holding: 3 → 5 (+2)

45% more capital invested

Capital invested by funds: $134K → $193K (+$59.9K)

0.23% more ownership

Funds ownership: 1% → 1.22% (+0.23%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$84.2K
2
Two Sigma Investments
Two Sigma Investments
New York
+$51.2K
3
State Street
State Street
Massachusetts
+$33.9K

Top Sellers

Rank Fund Capital Flow
1
Financial Engines Advisors
Financial Engines Advisors
California
-$104K
2
UBS Group
UBS Group
Switzerland
-$8.68K
3
Morgan Stanley
Morgan Stanley
New York
-$5

BIAF Hedge Fund Activity: Q1 2023 in Review

5 of the 6,285 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q1 2023, worth a combined $193K — up 45% from $134K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIAF positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $84.2K. The largest seller was Financial Engines Advisors, exiting entirely with an estimated $104K sold.

  • 5 institutional investors held bioAffinity Technologies (BIAF) as of Q1 2023, up from 3 in Q4 2022.
  • Funds reported $193K of bioAffinity Technologies stock for Q1 2023, up 45% quarter-over-quarter.
  • 3 funds opened new bioAffinity Technologies positions in Q1 2023 and 1 closed out, a net change of +2 holders.
  • The largest bioAffinity Technologies buyer in Q1 2023 was CAPTRUST Financial Advisors, an estimated $84.2K added.
  • The largest bioAffinity Technologies seller in Q1 2023 was Financial Engines Advisors, an estimated $104K sold.

Based on aggregated 13F filings for Q1 2023.